MRI-guided Ultrafocal HDR-brachytherapy for Localised Prostate Cancer Reply

被引：0
|
作者：
van Son, Marieke Juliet [1 ]
Peters, Max [1 ]
Moerland, Marinus A. [1 ]
van Zyp, Jochem R. N. van der Voort [1 ]
机构：
[1] Univ Med Ctr Utrecht, Dept Radiat Therapy, Utrecht, Netherlands
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2019年 / 104卷 / 05期
关键词：
19; GY; FRACTION;
D O I：
10.1016/j.ijrobp.2019.05.017
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1183 / 1184
页数：3
相关论文
共 20 条
  • [1] MRS-guided HDR brachytherapy boost to the dominant intraprostatic lesion in high risk localised prostate cancer
    Kazi, Aleksandra
    Godwin, Guy
    Simpson, John
    Sasso, Giuseppe
    BMC CANCER, 2010, 10
  • [2] MRI guided focal HDR brachytherapy for localized prostate cancer: Toxicity, biochemical outcome and quality of life
    Maenhout, Metha
    Peters, Max
    Moerland, Marinus A.
    Meijer, Richard P.
    van den Bosch, Maurice A. A. J.
    Frank, Steven J.
    Nguyen, Paul L.
    van Vulpen, Marco
    van Zyp, Jochem R. N. van der Voort
    RADIOTHERAPY AND ONCOLOGY, 2018, 129 (03) : 554 - 560
  • [3] Dosimetric impact of intrafraction changes in MR-guided high-dose-rate (HDR) brachytherapy for prostate cancer
    Rink, Alexandra
    Borg, Jette
    Simeonov, Anna
    O'Leary, Gerald
    Helou, Joelle
    Menard, Cynthia
    Chung, Peter
    Jaffray, David A.
    Berlin, Alejandro
    BRACHYTHERAPY, 2018, 17 (01) : 59 - 67
  • [4] HDR brachytherapy as monotherapy for prostate cancer: A systematic review with meta-analysis
    Viani, Gustavo Arruda
    Arruda, Caio Viani
    Assis Pellizzon, Antonio Cassio
    De Fendi, Ligia Issa
    BRACHYTHERAPY, 2021, 20 (02) : 307 - 314
  • [5] Single dose high-dose rate (HDR) brachytherapy (BT) as monotherapy for localised prostate cancer: Early results of a UK national cohort study
    Tharmalingam, Hannah
    Tsang, Yatman
    Ostler, Peter
    Wylie, James
    Bahl, Amit
    Lydon, Anna
    Ahmed, Imtiaz
    Elwell, Christine
    Nikapota, Ashok R.
    Hoskin, Peter J.
    RADIOTHERAPY AND ONCOLOGY, 2020, 143 : 95 - 100
  • [6] Feasibility of MRI targeted single fraction HDR brachytherapy for localized prostate carcinoma: ProFocAL-study
    Hass, Peter
    Fischbach, Frank
    Pech, Maciej
    Gawish, Ahmed
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (08) : 5397 - 5404
  • [7] Dose to the bladder neck in MRI-guided high-dose-rate prostate brachytherapy: Impact on acute urinary toxicity and health-related quality of life
    Sanmamed, Noelia
    Chung, Peter
    Berlin, Alejandro
    Adleman, Jenna
    Borg, Jette
    Lao, Bernadeth
    Ghai, Sangeet
    Weersink, Robert
    Simeonov, Anna
    Rink, Alex
    Menard, Cynthia
    Helou, Joelle
    BRACHYTHERAPY, 2019, 18 (04) : 477 - 483
  • [8] Single fraction of HDR brachytherapy for prostate cancer: Results of the SiFEPI phase II prospective trial
    Hannoun-Levi, Jean -Michel
    Chand-Fouche, Marie-Eve
    Pace-Loscos, Tanguy
    Gautier, Mathieu
    Gal, Jocelyn
    Schiappa, Renaud
    Pujol, Nina
    CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY, 2022, 37 : 64 - 70
  • [9] Assessment of integrated electromagnetic tracking for dwell position monitoring in a clinical HDR brachytherapy setting for prostate cancer
    Androulakis, Ioannis
    Schiphof-Godart, Jeremy
    van Heerden, Laura E.
    Luthart, Lorne
    Rijnsdorp, Rene
    Hoogeman, Mischa S.
    Westerveld, Henrike
    Christianen, Miranda E. M. C.
    Mens, Jan Willem M.
    van Paassen, Rosemarijn
    Negenman, Eva M.
    Nout, Remi A.
    Kolkman-Deurloo, Inger Karine K.
    RADIOTHERAPY AND ONCOLOGY, 2024, 200
  • [10] Health-related quality of life after ultrafocal salvage high-dose-rate brachytherapy for radiorecurrent prostate cancer: reporting the patient's perspective
    van Son, Marieke
    Monninkhof, Evelyn
    Peters, Max
    Lagendijk, Jan
    van Zyp, Jochem van der Voort
    CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY, 2020, 25 : 81 - 87
12